lunes, 4 de noviembre de 2019

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial HGM Heijerman et al, Lancet, October 31, 2019

Hot Topics of the Day|PHGKB

Cystic Fibrosis spelled out on die


Last Posted: Nov 03, 2019


No hay comentarios:

Publicar un comentario